Gaudium IVF and Women Health Limited (GAUDIUMIVF) — Announcement | 19 August 2026
Gaudium IVF reported 9.1% YoY revenue growth to ₹19.4 crores in Q1 FY27, driven by patient volume and international demand, though EBITDA margin moderated to 12.5% due to expansion investments. The company launched its first AI-powered Signature Lab in South Extension, plans to open 10 new hubs in FY27, and highlighted AI tools SiD and ERICA boosting success rates by 8%. With a strong balance sheet (₹8.12 crores cash, debt-to-equity of 0.04x) and ₹25 crores capex for FY27 hubs, management targets 30% revenue growth while maintaining FY26-adjusted EBITDA margins. International patient share stands at 25-30%, underscoring growing global demand for standardized, AI-enhanced fertility care.
About Gaudium IVF and Women Health Limited (GAUDIUMIVF)
Healthcare · Healthcare · Listed on NSE
📡 Get AI alerts when GAUDIUMIVF files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GAUDIUMIVF — Free💡 Ask AI about this filing
📊 More GAUDIUMIVF filings
- 🔴 Annual Report — 3 September 2026 My answer is yes.
- 🔴 Annual Report — 3 September 2026 Gaudium IVF and Women Health Limited announced that physical letters have been dispatched to shareho...
- 🟡 Board Meeting — 3 September 2026 Gaudium IVF and Women Health Ltd will hold its 11th AGM on September 28, 2026, via video conference,...
- 🔴 Financial Results — 13 August 2026 Gaudium IVF reported Q1FY27 revenue of ₹19.4 Cr, up 9.13% YoY, driven by mature hub growth and inter...
- 🔴 Offer Document — 13 August 2026 The Monitoring Agency Report for the quarter ended June 30, 2026 confirms that Gaudium IVF and Women...
🔥 Also filed on 19 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when GAUDIUMIVF files new disclosures
Track GAUDIUMIVF filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GAUDIUMIVF — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd